Patents by Inventor Rachelle Prantil-Baun

Rachelle Prantil-Baun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240075012
    Abstract: The present disclosure provides compositions and methods for inhibiting respiratory viral infections, inflammatory diseases, and/or respiratory inflammation.
    Type: Application
    Filed: August 11, 2023
    Publication date: March 7, 2024
    Applicant: President and Fellows of Harvard College
    Inventors: Haiqing Bai, Longlong Si, Rachelle Prantil-Baun, Donald E. Ingber
  • Publication number: 20230242918
    Abstract: Described herein are compositions and methods for inducing Type I interferon production. The compositions described comprise immunostimulatory oligonucleotide duplexes including a 5? terminal monophosphate-CUGA-3? (SEQ ID NO. 1) sequence. Compositions comprising the immunostimulatory oligonucleotide duplexes described can be used for the treatment of diseases or disorders that respond to interferons.
    Type: Application
    Filed: May 21, 2021
    Publication date: August 3, 2023
    Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
    Inventors: Longlong SI, Haiqing BAI, Donald E. INGBER, Crystal Yuri OH, Rachelle PRANTIL-BAUN
  • Publication number: 20220218668
    Abstract: The present disclosure provides compositions and methods for inhibiting respiratory viral infections, inflammatory diseases, and/or respiratory inflammation.
    Type: Application
    Filed: February 11, 2022
    Publication date: July 14, 2022
    Applicant: President and Fellows of Harvard College
    Inventors: Haiqing Bai, Longlong Si, Rachelle Prantil-Baun, Donald E. Ingber
  • Publication number: 20220202929
    Abstract: This disclosure provides immunogenic compositions and methods of producing immunogenic compositions sufficient to produce an antigen-specific immune response against variant influenza virus strains. Also provided herein are methods of identifying drug-resistant influenza virus strains.
    Type: Application
    Filed: May 19, 2020
    Publication date: June 30, 2022
    Applicant: President and Fellows of Harvard College
    Inventors: Donald E. Ingber, Longlong Si, Rachelle Prantil-Baun
  • Publication number: 20220193021
    Abstract: Provided herein, in some aspects, are combination therapies for inhibiting influenza virus infection.
    Type: Application
    Filed: April 30, 2020
    Publication date: June 23, 2022
    Applicant: President and Fellows of Harvard College
    Inventors: Longlong Si, Rachelle Prantil-Baun, Kambez Hajipouran Benam, Melissa Rodas, Ratnakar Potla, Donald E. Ingber
  • Patent number: 11229910
    Abstract: Described herein are microfluidic devices and systems for high density cell culture and/or high throughput cell assays. Methods of using the same are also provided herein. In some embodiments, the microfluidic devices and systems described herein provide rapid and automated trapping of single embryos in ordered arrays.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: January 25, 2022
    Assignees: President and Fellows of Harvard College, Tufts University
    Inventors: Richard Novak, Donald E. Ingber, Michael Levin, Rachelle Prantil-Baun
  • Publication number: 20190009274
    Abstract: Described herein are microfluidic devices and systems for high density cell culture and/or high throughput cell assays. Methods of using the same are also provided herein. In some embodiments, the microfluidic devices and systems described herein provide rapid and automated trapping of single embryos in ordered arrays.
    Type: Application
    Filed: August 12, 2016
    Publication date: January 10, 2019
    Applicants: President and Fellows of Harvard College, Tufts University
    Inventors: Richard Novak, Donald E. Ingber, Michael Levin, Rachelle Prantil-Baun